Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients…

By K. Conlon, E. Lugli, H. Welles, S. Rosenberg, A. Fojo, J. Morris, T. Fleisher, S. Dubois, L. Perera, D. Stewart and 13 more. Journal of Clinical Oncology, 2015

649 citations recorded by the source corpus.

Subfields: Immunology, Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/c2a04738a9abb916684dac2828653629448e8d72

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. G. Lal
2. S. Paul

Citations in the corpus

• Engineering strategies to overcome the current roadblocks in CAR T cell therapy (2019, neutral): “202 ) .”
• The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy (2017, positive): “This study establishes a safe tolerance of IL-15 in patients and also achieved reduction of lung lesions in two patients (152).”